Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cap-dependent endonuclease-IN-17 is a cap-dependent endonuclease (CEN) inhibitor. cap-dependent endonuclease-IN-17 exhibits antiviral activity (IC50: 1.29 μM) against influenza virus A/Hanfang/359/95 (H3N2).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | Cap-dependent endonuclease-IN-17 is a cap-dependent endonuclease (CEN) inhibitor. cap-dependent endonuclease-IN-17 exhibits antiviral activity (IC50: 1.29 μM) against influenza virus A/Hanfang/359/95 (H3N2). |
Molecular Weight | 563.47 |
Formula | C24H20F2N3O7PS |
CAS No. | 2649362-71-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cap-dependent endonuclease-IN-17 2649362-71-8 inhibitor inhibit